Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.

Satriano J, Sharma K, Blantz RC, Deng A.

Am J Physiol Renal Physiol. 2013 Sep 1;305(5):F727-33. doi: 10.1152/ajprenal.00293.2013. Epub 2013 Jul 3.

2.

Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.

Hayakawa S, Ohashi K, Shibata R, Kataoka Y, Miyabe M, Enomoto T, Joki Y, Shimizu Y, Kambara T, Uemura Y, Yuasa D, Ogawa H, Matsuo K, Hiramatsu-Ito M, van den Hoff MJ, Walsh K, Murohara T, Ouchi N.

J Am Soc Nephrol. 2015 Mar;26(3):636-46. doi: 10.1681/ASN.2014020210. Epub 2014 Jul 28.

PMID:
25071081
3.

A practical guide to subtotal nephrectomy in the rat with subsequent methodology for assessing renal and cardiac function.

Zhang Y, Kompa AR.

Nephrology (Carlton). 2014 Sep;19(9):552-61. doi: 10.1111/nep.12279.

PMID:
24845683
4.

Chronic renal insufficiency does not induce behavioral and cognitive alteration in rats.

Tóthová L, Bábíčková J, Borbélyová V, Filová B, Šebeková K, Hodosy J.

Physiol Behav. 2015 Jan;138:133-40. doi: 10.1016/j.physbeh.2014.10.027. Epub 2014 Oct 31.

PMID:
25447335
5.

Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.

van Koppen A, Joles JA, van Balkom BW, Lim SK, de Kleijn D, Giles RH, Verhaar MC.

PLoS One. 2012;7(6):e38746. doi: 10.1371/journal.pone.0038746. Epub 2012 Jun 19.

6.

Accelerated renal fibrosis in cardiorenal syndrome is associated with long-term increase in urine neutrophil gelatinase-associated lipocalin levels.

Entin-Meer M, Ben-Shoshan J, Maysel-Auslender S, Levy R, Goryainov P, Schwartz I, Barshack I, Avivi C, Sharir R, Keren G.

Am J Nephrol. 2012;36(2):190-200. doi: 10.1159/000341651. Epub 2012 Aug 8.

PMID:
22889806
7.

Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease.

van Koppen A, Joles JA, Bongartz LG, van den Brandt J, Reichardt HM, Goldschmeding R, Nguyen TQ, Verhaar MC.

Cell Transplant. 2012;21(10):2299-312. doi: 10.3727/096368912X636795.

PMID:
23231961
8.

Involvement of renal sympathetic nerve overactivation in the progression of chronic kidney disease in rats.

Kobuchi S, Tanaka R, Funai A, Suzuki R, Yazawa M, Tsutsui H, Ohkita M, Ayajiki K, Matsumura Y.

J Cardiovasc Pharmacol. 2014 Jan;63(1):9-15. doi: 10.1097/FJC.0000000000000016.

PMID:
24084211
9.

Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations.

Vrtovsnik F, Coester AM, Lopes-Barreto D, de Waart DR, Van der Wal AC, Struijk DG, Krediet RT, Zweers MM.

Perit Dial Int. 2010 Sep-Oct;30(5):558-69. doi: 10.3747/pdi.2008.00272. Epub 2010 Apr 26.

10.

Renal vascular structural properties and their alterations by removal of uraemic toxins in a rat model of chronic kidney disease.

Yamazaki H, Tomoda F, Koike T, Kinuno H, Sugimori H, Inoue H, Bannai K, Sugano M, Nishijima F.

Clin Exp Pharmacol Physiol. 2014 Mar;41(3):238-45. doi: 10.1111/1440-1681.12208.

PMID:
24471839
11.

[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].

Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.

Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. Serbian.

12.

Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.

Atkinson JM, Pullen N, Da Silva-Lodge M, Williams L, Johnson TS.

J Am Soc Nephrol. 2015 Aug;26(8):1925-37. doi: 10.1681/ASN.2014030303. Epub 2014 Nov 19.

PMID:
25411467
13.

Energy policy of the kidney: launch of AMPK as a novel therapeutic target.

Nangaku M.

Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F977-8. doi: 10.1152/ajprenal.00385.2013. Epub 2013 Jul 10. No abstract available.

14.

Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.

Burrell LM, Burchill L, Dean RG, Griggs K, Patel SK, Velkoska E.

Exp Physiol. 2012 Apr;97(4):477-85. doi: 10.1113/expphysiol.2011.063156. Epub 2011 Dec 23.

15.

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.

Guigas B, Bertrand L, Taleux N, Foretz M, Wiernsperger N, Vertommen D, Andreelli F, Viollet B, Hue L.

Diabetes. 2006 Apr;55(4):865-74.

16.

Pathophysiological role of vascular endothelial growth factor in the remnant kidney.

Schrijvers BF, Flyvbjerg A, Tilton RG, Rasch R, Lameire NH, De Vriese AS.

Nephron Exp Nephrol. 2005;101(1):e9-15. Epub 2005 May 27.

PMID:
15925906
17.

Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats.

Paterno JC, Bergamaschi CT, Campos RR, Higa EM, Soares MF, Schor N, Freire AO, Teixeira VP.

Kidney Blood Press Res. 2012;35(5):355-64. doi: 10.1159/000336095. Epub 2012 Apr 3.

PMID:
22473039
18.

The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

Johnson TS, Griffin M, Thomas GL, Skill J, Cox A, Yang B, Nicholas B, Birckbichler PJ, Muchaneta-Kubara C, Meguid El Nahas A.

J Clin Invest. 1997 Jun 15;99(12):2950-60.

19.
20.

SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.

Chen LH, Advani SL, Thai K, Kabir MG, Sood MM, Gibson IW, Yuen DA, Connelly KA, Marsden PA, Kelly DJ, Gilbert RE, Advani A.

PLoS One. 2014 Mar 17;9(3):e92227. doi: 10.1371/journal.pone.0092227. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk